These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36729295)

  • 1. Identifying Attributes for a Value Assessment Framework in China: A Qualitative Study.
    Zhang M; Bao Y; Yang Y; Kimber M; Levine M; Xie F
    Pharmacoeconomics; 2023 Apr; 41(4):439-455. PubMed ID: 36729295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks.
    Zhang M; Bao Y; Lang Y; Fu S; Kimber M; Levine M; Xie F
    Value Health; 2022 Feb; 25(2):302-317. PubMed ID: 35094803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Technology Assessment and Its Use in Drug Policies in China.
    Zhen X; Sun X; Dong H
    Value Health Reg Issues; 2018 May; 15():138-148. PubMed ID: 29729645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.
    Uzochukwu BSC; Okeke C; O'Brien N; Ruiz F; Sombie I; Hollingworth S
    Global Health; 2020 Jul; 16(1):58. PubMed ID: 32641066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
    Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
    Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the perspectives and preferences for HTA across German healthcare stakeholders using a multi-criteria assessment of a pulmonary heart sensor as a case study.
    Wahlster P; Goetghebeur M; Schaller S; Kriza C; Kolominsky-Rabas P;
    Health Res Policy Syst; 2015 Apr; 13():24. PubMed ID: 25928535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting.
    Angelis A; Montibeller G; Hochhauser D; Kanavos P
    BMC Med Inform Decis Mak; 2017 Oct; 17(1):149. PubMed ID: 29073892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'The problem is small enough, the problem is big enough': a qualitative study of health technology assessment and public policy on drug funding decisions for children.
    Denburg AE; Giacomini M; Ungar WJ; Abelson J
    Int J Equity Health; 2020 Mar; 19(1):45. PubMed ID: 32228588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using health technology assessment for informing coverage decisions in Thailand.
    Mohara A; Youngkong S; Velasco RP; Werayingyong P; Pachanee K; Prakongsai P; Tantivess S; Tangcharoensathien V; Lertiendumrong J; Jongudomsuk P; Teerawattananon Y
    J Comp Eff Res; 2012 Mar; 1(2):137-46. PubMed ID: 24237374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What steps can researchers take to increase research uptake by policymakers? A case study in China.
    Wu S; Khan M; Legido-Quigley H
    Health Policy Plan; 2020 Jul; 35(6):665-675. PubMed ID: 32386212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.
    Janssens R; Russo S; van Overbeeke E; Whichello C; Harding S; Kübler J; Juhaeri J; Bywall KS; Comanescu A; Hueber A; Englbrecht M; Nikolenko N; Pravettoni G; Simoens S; Stevens H; Hermann R; Levitan B; Cleemput I; de Bekker-Grob E; Veldwijk J; Huys I
    Patient; 2019 Oct; 12(5):513-526. PubMed ID: 31222436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEVELOPMENT OF THE ONTARIO DECISION FRAMEWORK: A VALUES BASED FRAMEWORK FOR HEALTH TECHNOLOGY ASSESSMENT.
    Krahn M; Miller F; Bayoumi A; Brooker AS; Wagner F; Winsor S; Giacomini M; Goeree R; Schünemann H; van der Velde G; Petersen S; Sikich N; Dhalla I
    Int J Technol Assess Health Care; 2018 Jun; 34(3):290-299. PubMed ID: 29987995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Technology Assessment Development in Vietnam: A Qualitative Study of Current Progress, Barriers, Facilitators, and Future Strategies.
    Lee HY; Nguyen TT; Park S; Hoang VM; Kim WH
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International comparison of comparative effectiveness research in five jurisdictions: insights for the US.
    Levy AR; Mitton C; Johnston KM; Harrigan B; Briggs AH
    Pharmacoeconomics; 2010; 28(10):813-30. PubMed ID: 20831289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(15):1-160. PubMed ID: 33240456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.